Omega Healthcare Investors (OHI) to Announce Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI) will likely be posting its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect Omega Healthcare Investors to post earnings of $0.5060 per share and revenue of $267.6560 million for the quarter. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Parties may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm had revenue of $322.95 million for the quarter, compared to analysts’ expectations of $264.07 million. During the same period in the previous year, the firm posted $0.75 EPS. The firm’s quarterly revenue was up 16.7% compared to the same quarter last year. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Omega Healthcare Investors Trading Up 1.9%

Shares of Omega Healthcare Investors stock opened at $50.52 on Wednesday. The firm has a market capitalization of $15.04 billion, a price-to-earnings ratio of 24.40, a PEG ratio of 2.12 and a beta of 0.58. Omega Healthcare Investors has a fifty-two week low of $38.02 and a fifty-two week high of $50.75. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. The stock has a 50 day moving average of $47.28 and a 200 day moving average of $46.31.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 5.3%. The ex-dividend date of this dividend was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio is 129.47%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. Truist Financial reduced their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a report on Tuesday, June 9th. Scotiabank decreased their target price on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Raymond James Financial started coverage on shares of Omega Healthcare Investors in a research note on Tuesday, June 16th. They set an “outperform” rating and a $50.00 target price for the company. Finally, Barclays began coverage on shares of Omega Healthcare Investors in a research report on Tuesday, July 7th. They set an “underweight” rating and a $51.00 price target for the company. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $48.50.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of institutional investors have recently modified their holdings of the company. State Street Corp lifted its stake in Omega Healthcare Investors by 4.8% during the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after acquiring an additional 671,473 shares in the last quarter. Invesco Ltd. grew its position in Omega Healthcare Investors by 8.6% in the 4th quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock valued at $238,059,000 after acquiring an additional 424,024 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Omega Healthcare Investors by 4.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock valued at $197,927,000 after acquiring an additional 174,062 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Omega Healthcare Investors by 2.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,314,384 shares of the real estate investment trust’s stock valued at $191,305,000 after acquiring an additional 103,201 shares in the last quarter. Finally, Deutsche Bank AG increased its stake in Omega Healthcare Investors by 12.2% during the fourth quarter. Deutsche Bank AG now owns 3,615,837 shares of the real estate investment trust’s stock worth $160,326,000 after purchasing an additional 392,575 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.